Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients With Stenotic Valvular Heart Disease Undergoing Caesarean Section

NCT05110482 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT05110482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05110482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients With Stenotic Valvular Heart Disease Undergoing Caesarean Section
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2021
Completion date
June 30, 2023
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect of oxytocic drugs